SOURCE: Trend Exploration

January 19, 2011 16:15 ET

TRDX's Preferred Distribution Subsidiary Targets 2nd Quarter for Launch of New Pharmaceutical Distribution Division; Revenue Growth Expected

JERICHO, NY--(Marketwire - January 19, 2011) - SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. ("TRDX" or the "Company") (PINKSHEETS: TRDX) today announces that, Preferred Distribution, Inc. its medical and dental supplies distribution subsidiary ("Preferred"), ( is targeting the second quarter of 2011 for the launch of its new pharmaceutical distribution division.

As previously announced the implementation which initially consists of Preferred registering as an out-of-state wholesaler of pharmaceuticals is well underway. Preferred has successfully registered in New York, Florida and Washington. Additional registrations are pending in New Jersey and California.

Dr. Jan Stahl, CEO of TRDX, commented: "Preferred expects approvals in New Jersey and California in the next 60-90 days. A launch implementation plan is currently being formulated and as more pieces are in place will be solidified. We fully expect this new division to delivery revenue growth to the TRDX income statement."

The Company looks forward to sharing our progress as more developments occur.

About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent ( is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information